Str8tEdge » 24 Nov 2021, 10:59 pm » wrote: ↑
This is exactly why you’re ignored.
The fact 60% of Americans are vaccinated and Biden still has more deaths than Trump who did NOT have a vaccine available makes Biden’s failure even worse.
You are stupid, uneducated and the worst **** Hack This board has ever witnessed.
Now back on ignore for your *******.
Let alone that countries that keep better track
than our filthy lying propagandists for Big Pharma pretty much answers any questions about who's doing the dying.
Negative Vaccine Efficacy of COVID vaxxes against Omicron
Or take the example of the "irrepressible monster" in
87% vaxxed Australia:
viewtopic.php?f=3&t=68106
https://www.health.nsw.gov.au/Infectiou ... ports.aspx
"There were 80 COVID-19 deaths reported this week (ending 11 June 2022). Of these, all were eligible for a third dose of a COVID-19 vaccine but only 49
(61%) had received a third dose. Six of the deaths reported were in people aged under 65 years. Deaths may not have occurred in the week in which they were reported."
So 61% of the COVID dead even had a booster jab, yet death rates are a multiple of what they were at any time since the beginning of the pandemic.
No reference to unvaxxed in that report that I spotted offhand.
It's certainly not the early treated at home unvaxxed that are dying.
Overcoming the COVID-19 Darkness: Two Doctors Successfully Treated 7000 Patients
Methods:
We examine the results of two similar multidrug protocols with data from the immediate county. Protocol 1 uses of hydroxychloroquine, an agent with apparent antiviral reactivity against SARS-CoV-2, two antibiotics (azithromycin, doxycycline), along with a multivitamin pack (including zinc, vitamin C, vitamin D, and others), and with selective use of one or a combination of inhaled budesonide, dexamethasone, prednisone, or other treatments deemed appropriate. Protocol 2 includes all of these options, plus ivermectin where deemed appropriate by physicians. Results were then stratified according to disease severity of patients when first seen by doctors. Among 4,385
individuals sorted in both protocols and three severity levels, combined or excluded from this study, the mean age was 40.5±18.2 years and 12.8% were less than twenty years of age.
Primary Results:
Among 3,962 patients treated for mild COVID-19, prior to the development of moderate or severe levels of disease stage, none died as compared to 3.03% (2.25% risk adjusted) (OR = 0.0000, p < 0.0001)
in the same county and time period. Of those 3,962 patients, 0.05% were hospitalized as compared to 22.68% (20.76% risk adjusted) (OR = 0.0019, p < 0.0001)
in the same county and time period. Differences in outcomes among All Valley Urgent Care patients based on the severity at the time of presentation were observed. Those patients receiving treatment while presenting mild COVID-19 were less often hospitalized (OR = 0.0293, p < 0.0001) and suffered lower mortality (OR = 0.0000, p = 0.0008).
Results suggest a highly significant impact for these multidrug protocols. No serious side effects, including cardiac side effects, were observed.